8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
DANAHER CORP /DE/ (DHR)

On Jan 12, 2026 Danaher ($DHR) furnished a press release and presentation slides ahead of its Jan 13 J.P.

Filed with the SEC on · Summarized by InvestorsBot

On Jan 12, 2026 Danaher ($DHR) furnished a press release and presentation slides ahead of its Jan 13 J.P. Morgan Healthcare Conference webcast, disclosing estimated Q4 2025 and full‑year 2025 financial performance. 📢📈 #DHR #JPMHealthcare #Earnings

The materials were furnished under Item 2.02 (not “filed”) — these are preliminary/estimated Q4 and 2025 results, not subject to Section 18 filing liability and not incorporated by reference unless expressly stated. ℹ️ $DHR #Guidance #Investing

Investors should monitor Danaher’s Jan 13 JPM webcast and the attached slides for the detailed estimated 2025 metrics and any updates to guidance. 🗓️🎙️ $DHR #JPMHealthcare #Earnings

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from DANAHER CORP /DE/

Danaher ($DHR) filed a Form 8‑K (Item 9.01) on Feb 17, 2026 — furnished Exhibit 99.1 (press release dated…

8-K · February 17, 2026

Danaher ($DHR) to buy Masimo ($MASI) for $180.00/share in cash under a Merger Agreement dated Feb 16,…

8-K · February 17, 2026

Danaher ($DHR) filed an 8‑K (Item 9.01) on 2/10/2026 furnishing Exhibit 104 — Cover Page Interactive Data…

8-K · February 10, 2026

Danaher director Jessica L.

8-K · February 10, 2026

Danaher filed an 8‑K (dated 1/28/2026) attaching a press release “Danaher Reports Fourth Quarter and Full…

8-K · January 28, 2026

Danaher ($DHR) furnished an 8‑K (Item 2.02) on Jan 28, 2026 announcing FY2025 financial results for the…

8-K · January 28, 2026